本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Entrada Therapeutics, Inc.

9.06
-0.0666-0.73%
成交量:5.83万
成交额:52.69万
市值:3.41亿
市盈率:5.39
高:9.46
开:9.17
低:8.83
收:9.13
数据加载中...
2024/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/07/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/26

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/06/24

重要事件披露

Form 8-K - Current report
2024/06/24

重要事件披露

Form 8-K - Current report
2024/06/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/13

重要事件披露

Form 8-K - Current report
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/17

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/30

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/25

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/24

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities